Very likely this is the mechanism that explains the tumor growth inhibition of xenografts deriving from α2δ2-overexpressing LNCaP cells, which results in being more tumorigenic than control LNCaP cells, due to their increased proliferation rate, progression and ability to stimulate angiogenesis through a higher secretion of VEGF [172]. This evidence concerns the gene VEGFA and neoplasm.